Results 101 to 110 of about 70,358 (244)

Risk factors in gastric cancer [PDF]

open access: yes, 2010
STATE OF THE ART: Gastric cancer (GC) is still a major health problem worldwide due to its frequency, poor prognosis and limited treatment options. At present prevention is likely to be the most effective means of reducing the incidence and mortality ...
COMPARE, DEBORA   +2 more
core  

Correction to: Embedding similarities between embryos and circulating tumor cells: fundamentals of abortifacients used for cancer metastasis chemoprevention [PDF]

open access: gold, 2021
Jie Wang   +9 more
openalex   +1 more source

Chemoprevention [PDF]

open access: yesJournal of Cellular Biochemistry, 1992
W. Weber, S. Kubba
openaire   +2 more sources

Chemoprevention of metastasis

open access: yesOncotarget, 2014
Cancer chemoprevention employs natural, synthetic, or biologic substances to reverse, suppress, or prevent the development of cancer. Initially these agents were developed to reduce cancer risk or retard its development, but were not intended to treat cancer. Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is used clinically to prevent polyp
Nancy J, Emenaker   +2 more
openaire   +2 more sources

Duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4T1 cells

open access: yesIndonesian Journal of Biotechnology
Triple‐negative breast cancer (TNBC) faces significant treatment challenges due to its resistance to chemotherapy and high‐rate metastatic occurrence.
Faaza Aulia Rahman   +5 more
doaj   +1 more source

Effect of DNA repair deficiencies on the cytotoxicity of resveratrol [PDF]

open access: yes, 2015
Numerous preclinical studies have shown that the naturally-occurring polyphenol resveratrol may produce health-beneficial effects in a variety of disorders, including cancer, diabetes, Alzheimer, and cardiovascular diseases.
Burgos Morón, Estefanía   +5 more
core  

A patient with newly diagnosed breast cancer found to have mosaic TP53 likely pathogenic variant

open access: yes
CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Hetal D. Mistry   +8 more
wiley   +1 more source

Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles

open access: yesNature Communications, 2019
Oncogenic exosomes can circulate in the blood, but their selective removal has not been possible. Here the authors show that aptamer-functionalised mesoporous silica nanoparticles can find to a specific population of circulating exosomes and eliminate ...
Xiaodong Xie   +17 more
doaj   +1 more source

Vanadium(III)--cysteine enhances the sensitivity of murine breast adenocarcinoma cells to cyclophosphamide by promoting apoptosis and blocking angiogenesis

open access: yesTumor Biology, 2017
Various epidemiological and preclinical studies have already established the cancer chemopreventive potential of vanadium-based compounds. In addition to its preventive efficacy, studies have also indicated the abilities of vanadium-based compounds to ...
Abhishek Basu   +5 more
doaj   +1 more source

Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib

open access: yesJournal of Experimental & Clinical Cancer Research, 2019
Background Sorafenib is approved as a standard therapy for advanced hepatocellular carcinoma (HCC), but its clinical application is limited due to moderate therapeutic efficacy and high incidence of acquired resistance resulted from elevated levels of ...
Ning Zheng   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy